A study investigating claims data from over 1,000 patients battling inflammatory bowel disease (IBD) between January 2022 and December 2022 found that SonarMD’s technology-enabled patient engagement leads to 10 times fewer hospital admissions and emergency department (ED) visits among patients with IBD. In addition to observing a 10-fold reduction in hospital and ED visits between the engaged and unengaged groups, the analysis showed two-thirds of all inpatient admissions and ED visits could be attributed to the unengaged group, even though they only accounted for 20% of the total patient population.
Dr. Lawrence Kosinski, a gastroenterologist-CMO of SonarMD, and the study’s lead author emphasized the importance of proactive patient engagement in preventing unnecessary hospital admissions and ED visits. “You can’t manage who you can’t engage. And as physicians, we are vulnerable to familiarity bias, meaning it’s easy to overestimate how much we engage our patients,” said Dr. Kosinski.
SonarMD’s technology-enabled care coordination platform was used to engage patients in the study. The platform’s digital tools help proactively detect patient deterioration and alert care teams so they can intervene before higher acuity care is needed. By partnering with health plans and providers using value-based contracts, SonarMD ensures optimal GI care and successfully engages an average of 85% of patients, driving 15% cost savings per member per year.
Beth Houck, CEO of SonarMD, commented on the research, highlighting the challenge of managing outcomes for unengaged patients and how SonarMD helps practices overcome the first challenge of managing patients with complex chronic disease – patient engagement. “Our end-to-end care coordination program helps specialists and care teams focus on providing the best possible patient experience, so patients can stay healthier and out of the hospital,” said Houck.
To learn more about this research at the Crohn’s & Colitis Congress®, visit poster P020, The Importance of Patient Engagement in the Management of Inflammatory Bowel Disease, during the poster sessions and reception on January 26. All abstracts presented at the event will also be published as an online supplement to Gastroenterology and Inflammatory Bowel Diseases.
SonarMD’s technology and human support aim to reimagine care for complex chronic GI diseases by predicting clinical deterioration and making it easier for patients and specialists to proactively address problems before they become health emergencies. More information is available at SonarMD.com.
For further information, contact Patty Keiler at 312-550-5394.
SOURCE SonarMD
Source link